Related Experiment Video
Updated: Jan 13, 2026
Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
Published on: December 27, 2024
Spinal astrocytic EAATs mediate endothelin-1-induced breakthrough cancer pain in mice
Siqing Jiang1, Dong Huang2, Lihua Huang3
1Department of Lung Cancer and Gastrointestinal Oncology Medicine, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Background:
Breakthrough cancer pain (BTcP) lacks representative animal models. The roles of spinal excitatory amino acid transporters (EAATs) in BTcP remain unclear.
Methods:
We established a modified BTcP mouse model using lung cancer bone metastasis and endothelin-1 (ET-1) injections once daily on postoperative days 16-18, with validation through behavioral and electrophysiological assessments. Spinal EAAT1, EAAT2 and connexin 43 (Cx43) were investigated. Mice were administered intrathecal ceftriaxone (EAAT2 activator), Gap26 (gap junction blocker), or control agents.
Results:
The BTcP model showed reduced pain thresholds and function, accompanied by decreased EAAT1/EAAT2 and increased phosphorylated C×43 (p-Cx43) in spinal astrocytes. Ceftriaxone reversed pain hypersensitivity, upregulated EAAT2, and reduced p-Cx43 without affecting EAAT1/total Cx43. Gap26 increased EAAT1/EAAT2, decreased Cx43/p-Cx43, and alleviated pain behaviors.
Conclusion:
This optimized ET-1 model provides a robust platform for BTcP research. Spinal EAATs, downregulation and C×43 activation, contribute to BTcP pathogenesis, and both are potential therapeutic targets of BTcP.
More Related Videos
08:16Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022
07:30A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017